Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290
Zaohua Huang(Florida International University), Alexander I. Agoulnik(Florida International University), Irina U. Agoulnik(University of South Florida), Amaya Bueno(Florida International University), Brian A. Ho(Florida International University), Juan Marugán(National Institutes of Health), Elena Barnaeva(National Center for Advancing Translational Sciences), Ross A. D. Bathgate(The University of Melbourne), Xin Hu(Discovery Institute), Jingbo Xiao(National Center for Advancing Translational Sciences), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Courtney Myhr(Florida International University), Noel Southall(National Center for Advancing Translational Sciences)
Cited by 21
Related Papers
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse
|Nature Genetics|2000|351